Press communication
Lund, Sweden, April 9, 2024
This is a translation of the Swedish press release published 2024-04-09

Neola Medical AB (publ) announces that the Annual report of 2023 now is available at the company’s website, and attached to the press release.

Read the press release and the Annual report of 2023 (in Swedish) here: Press release with Annual report 2023

For further information, contact:
Hanna Sjöström, CEO Neola Medical, phone: +46 (0)760-10 71 16, e-mail:

Neola Medical AB (publ) develops medical technology device for continuous monitoring of preterm born infants’ lungs. Immediate detection of complications provides the possibility of early treatment and improved health care. The patented technology is based on a spectroscopic method developed at Lund University in Sweden. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at The company’s Certified Adviser is FNCA Sweden AB.